Positiveid Corp. (PSID) 0.0403 $PSID
PositiveID Analyst Inspection: Emerging Contender in BioThreat Detection - First Ever Revenue Guidance and Backlog Position Company for Increased Visibility and Traction - by SmallCapTraders.com
PR Newswire - Wed Jul 23, 8:30AM CDT
PositiveID Corp. (OTCQB: PSID), based in Delray Beach, Fla., is an emerging player in the bio-threat detection market, that develops molecular diagnostic systems for bio-threat detection and rapid medical testing. The Company's proprietary airborne pathogen detection system called M-BAND (Microfluidic Bio-agent Autonomous Networked Detector), was developed under contract with the U.S. Department of Homeland Security ("DHS"
Science & Technology directorate, and $30 million of contract funding.
PositiveID wins new purchase order to support M-BAND System for US government to protect the nation's warfighters and defenders
M2 - Fri Jul 18, 9:56AM CDT
Biological detection company PositiveID (Other OTC
SID) disclosed on Thursday the receipt of a new purchase order for the continued testing and evaluation of its M-BAND (Microfluidic Bioagent Autonomous Networked Detector) from a large government contractor in support of an existing US government contract.
PositiveID Receives New Order to Support M-BAND System for U.S. Government Contract
GlobeNewswire - Thu Jul 17, 6:11AM CDT
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that it has received a new order from a large government contractor for the continued testing and evaluation of PositiveID's M-BAND (Microfluidic Bioagent Autonomous Networked Detector) in support of an existing U.S. government contract. In keeping with contractual obligations the contractor and program have not been named. As a result of this new purchase order, the company has increased its 2014/2015 revenue and backlog (backlog added to revenue recognized) estimate from $3.3 million to $3.5 million, and is reiterating its revenue guidance of $4-10 million through the end of 2015 (2014 and 2015 combined).
PositiveID Corp. Chairman and CEO William J. Caragol Conducts New Interview with The Green Baron Report
GlobeNewswire - Tue Jul 01, 7:11AM CDT
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, announced today that its Chairman and CEO William J. Caragol has conducted a new, audio-taped webcast interview with The Green Baron Report. In the interview, Mr. Caragol provides an update for PositiveID's stockholders and the investment community on the Company's recent developments and growth plans. Unrestricted access to the webcast is now available on the "Webcasts" page at http://www.thegreenbaron.com/Webcasts.htm .
PositiveID Publishes Updated Report on Its BioThreat Detection and Diagnostics Solutions and Market Opportunities
GlobeNewswire - Mon Jun 30, 6:00AM CDT
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, today published an updated report on its 2014 progress and future market opportunities for its homeland security and medical diagnostics technologies.
Quality Systems Teams Up With 3M Health Information Systems - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 12:50PM CDT
Quality Systems (QSII) continues to report a fall in earnings and revenues but we are still optimistic about the company given the continued strength in its NextGen subsidiary as well as the expected benefit from its Mirth acquisition.
Cerner Enters New Agreement with North Carolina's Mission Health - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 12:40PM CDT
Under the new agreement, signed on Mar 28, Cerner Corporation (CERN) will help Mission Health control IT costs, align strategies, and improve the quality of care.
St. Jude Medical Hits New 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 2:45PM CDT
Considering the last one month, shares of St. Jude Medical (STJ) returned 8.9%, higher than the S&P 500 return of 5.0%.
St. Jude Medical Gets Award for Leadless Pacemaker - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 12:10PM CDT
A congress committee of electrophysiologists has chosen St. Jude Medical's (STJ) Nanostim leadless pacemaker for the award being the most innovative product in electrophysiology and cardiac technique
PositiveID's Chairman and CEO Discusses Progress with Bio-Threat Detection Technology and Revenue Guidance
PR Newswire - Mon Jun 16, 7:00AM CDT
(Investorideas.com Newswire) Investorideas.com, a leader in research for independent investors presents an exclusive Q&A interview with Mr. William J. Caragol, Chairman and Chief Executive Officer of PositiveID Corporation (OTCBB: PSID), a developer of biological detection and diagnostics solutions. Mr. Caragol discusses the current status and opportunities for its bio-threat detection technology and recently announced revenue guidance.
OTC Sector Trading List: Strategic Global Investments, Inc. Alkame Holdings, Inc. One World Holdings, Inc. Positiveid Corporation, Powerdyne International, Inc.
PR Newswire Europe - Wed Jun 11, 8:45AM CDT
LONDON, June 10, 2014 /PRNewswire/ --
In a New Audio Interview at SmallCapVoice.com, PositiveID Corporation Discusses Its Recently Announced Revenue Guidance of $4-10 Million Over the Next 18 Months
GlobeNewswire - Wed Jun 11, 7:00AM CDT
SmallCapVoice.com, Inc. announced today that a new audio interview with PositiveID Corporation ("PositiveID" or the "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, is now available. The interview can be heard at http://smallcapvoice.com/blog/6-9-14-smallcap...-corp-psid.
PositiveID announces first-ever revenue guidance of USD4m-10m over next 18 months to increase its bio-threat detection technologies and programmes
M2 - Mon Jun 09, 7:35AM CDT
Biological detection company PositiveID (Other OTC SID) disclosed on Friday the submission of bids and proposals in conjunction with several large commercial partners under the new US government procurements for bio-threat detection rise.
PositiveID Issues First-Ever Revenue Guidance of $4-10 Million Over Next 18 Months as Government Procurements for Bio-Threat Detection Increase
GlobeNewswire - Fri Jun 06, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, announced today that it has submitted bids and proposals in conjunction with several large commercial partners in response to a pick-up in new U.S. government procurements for bio-threat detection. As a result, PositiveID is issuing its first-ever revenue guidance of $4-10 million over the next 18 months, $3.3 million of which is already in backlog.
PositiveID Corporation Updates Stockholders on 2014 Progress
GlobeNewswire - Tue May 27, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, today provided an update to stockholders on its 2014 progress. Year to date, the Company has achieved several key goals through the signing of agreements with large commercial and federal government organizations, including revenue generation.
Limitless Venture Group's Stock Volume Soars On News of Hemp-Based Products
ACCESSWIRE - Wed Apr 02, 8:41AM CDT
Limitless Venture Group Inc.'s (OTCPINK: LVGI) stock volume skyrocketed Apr. 1, with 292,012,825 shares changing hands, nearly three times more than its three-month average volume of 107,767,353 shares.
The Market and Potential for Molecular Point of Care Diagnostics Report Provides Market Estimates up to 2018
M2 - Mon Mar 31, 11:27AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gb6tbz/the_market_and) has announced the addition of the "The Market and Potential for Molecular Point of Care Diagnostics" report to their offering. The molecular diagnostic market and the point-of-care (POC) testing markets are two of the fastest growing segments of the overall IVD market. Historically, these have been completely different market segments. Not anymore. There has been a growing interest in developing molecular diagnostic platforms that can be used in POC settings. Indeed, as this new market research report details, the emerging area of rapid molecular POC testing has attracted over $650 million in investments and financings over the past five years (2009 to 2013). The Market and Potential for Molecular Point of Care Diagnostics, offers a quantitative assessment of the molecular diagnostic market, and of the point-of-care (POC) testing market, and then looks at the emerging field of molecular diagnostic POC testing. Many companies are developing molecular diagnostic platforms and assays that are designed to for near-patient or POC testing, and the earliest of these systems are starting to reach the market. The initial market focus for most of these companies is on infectious disease testing, where rapid test results generate important actionable information that physicians can use to make treatment decisions. Over 75 companies involved in this market are profiled in this report. As expected with any group of start-up companies, many are struggling or are surviving on limited financial resources. However, some new companies that are focusing on molecular diagnostic POC testing have received significant investments. Some of the Companies Mentioned: - Abacus Diagnostica Oy - bioMerieux sa - Canon U.S. Life Sciences - DiaSorin S.p.A. - Espira, Inc. - Focus Diagnostics, Inc. - GenePOC Inc. - Instrumentation Laboratory - Lumora Ltd - Meridian Bioscience, Inc. - NetBio, Inc. - OptiGene Ltd. - PositiveID Corporation - QIAGEN N.V - Spartan Bioscience Inc. - Veredus Laboratories - Wave 80 Biosciences - Xagenic Inc. For more information visit http://www.researchandmarkets.com/research/gb...market_and About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
PositiveID Signs Agreement With Unit of UTC Aerospace Systems for U.S. Government Contract
GlobeNewswire - Mon Mar 31, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, is proud to announce that it has signed a contract with UTC Aerospace Systems' ISR & Space Systems unit to support a contract for the U.S. Department of Defense ("DoD" . This contract is expected to be performed over the next seven months, between March and September, 2014.
PositiveID Corporation's CEO to Present at InvestorIdeas.com Security and Defense Conference on March 11, 2014 in New York City
GlobeNewswire - Wed Mar 05, 7:42AM CST
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that its Chairman and CEO, William J. Caragol, will present at the InvestorIdeas.com Security and Defense Conference at 3:30 pm on March 11, 2014, at the New York Hilton Midtown in New York City. The Company's presentation will be posted in the Investors & Media section of its website under Events & Presentations.
PositiveID Analyst Inspection: Emerging Contender in BioThreat Detection - First Ever Revenue Guidance and Backlog Position Company for Increased Visibility and Traction - by SmallCapTraders.com
PR Newswire - Wed Jul 23, 8:30AM CDT
PositiveID Corp. (OTCQB: PSID), based in Delray Beach, Fla., is an emerging player in the bio-threat detection market, that develops molecular diagnostic systems for bio-threat detection and rapid medical testing. The Company's proprietary airborne pathogen detection system called M-BAND (Microfluidic Bio-agent Autonomous Networked Detector), was developed under contract with the U.S. Department of Homeland Security ("DHS"
Science & Technology directorate, and $30 million of contract funding. PositiveID wins new purchase order to support M-BAND System for US government to protect the nation's warfighters and defenders
M2 - Fri Jul 18, 9:56AM CDT
Biological detection company PositiveID (Other OTC
SID) disclosed on Thursday the receipt of a new purchase order for the continued testing and evaluation of its M-BAND (Microfluidic Bioagent Autonomous Networked Detector) from a large government contractor in support of an existing US government contract. PositiveID Receives New Order to Support M-BAND System for U.S. Government Contract
GlobeNewswire - Thu Jul 17, 6:11AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that it has received a new order from a large government contractor for the continued testing and evaluation of PositiveID's M-BAND (Microfluidic Bioagent Autonomous Networked Detector) in support of an existing U.S. government contract. In keeping with contractual obligations the contractor and program have not been named. As a result of this new purchase order, the company has increased its 2014/2015 revenue and backlog (backlog added to revenue recognized) estimate from $3.3 million to $3.5 million, and is reiterating its revenue guidance of $4-10 million through the end of 2015 (2014 and 2015 combined). PositiveID Corp. Chairman and CEO William J. Caragol Conducts New Interview with The Green Baron Report
GlobeNewswire - Tue Jul 01, 7:11AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, announced today that its Chairman and CEO William J. Caragol has conducted a new, audio-taped webcast interview with The Green Baron Report. In the interview, Mr. Caragol provides an update for PositiveID's stockholders and the investment community on the Company's recent developments and growth plans. Unrestricted access to the webcast is now available on the "Webcasts" page at http://www.thegreenbaron.com/Webcasts.htm . PositiveID Publishes Updated Report on Its BioThreat Detection and Diagnostics Solutions and Market Opportunities
GlobeNewswire - Mon Jun 30, 6:00AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today published an updated report on its 2014 progress and future market opportunities for its homeland security and medical diagnostics technologies. Quality Systems Teams Up With 3M Health Information Systems - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 12:50PM CDT
Quality Systems (QSII) continues to report a fall in earnings and revenues but we are still optimistic about the company given the continued strength in its NextGen subsidiary as well as the expected benefit from its Mirth acquisition.
Cerner Enters New Agreement with North Carolina's Mission Health - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 12:40PM CDT
Under the new agreement, signed on Mar 28, Cerner Corporation (CERN) will help Mission Health control IT costs, align strategies, and improve the quality of care.
St. Jude Medical Hits New 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 2:45PM CDT
Considering the last one month, shares of St. Jude Medical (STJ) returned 8.9%, higher than the S&P 500 return of 5.0%.
St. Jude Medical Gets Award for Leadless Pacemaker - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 12:10PM CDT
A congress committee of electrophysiologists has chosen St. Jude Medical's (STJ) Nanostim leadless pacemaker for the award being the most innovative product in electrophysiology and cardiac technique
PositiveID's Chairman and CEO Discusses Progress with Bio-Threat Detection Technology and Revenue Guidance
PR Newswire - Mon Jun 16, 7:00AM CDT
(Investorideas.com Newswire) Investorideas.com, a leader in research for independent investors presents an exclusive Q&A interview with Mr. William J. Caragol, Chairman and Chief Executive Officer of PositiveID Corporation (OTCBB: PSID), a developer of biological detection and diagnostics solutions. Mr. Caragol discusses the current status and opportunities for its bio-threat detection technology and recently announced revenue guidance.
OTC Sector Trading List: Strategic Global Investments, Inc. Alkame Holdings, Inc. One World Holdings, Inc. Positiveid Corporation, Powerdyne International, Inc.
PR Newswire Europe - Wed Jun 11, 8:45AM CDT
LONDON, June 10, 2014 /PRNewswire/ --
In a New Audio Interview at SmallCapVoice.com, PositiveID Corporation Discusses Its Recently Announced Revenue Guidance of $4-10 Million Over the Next 18 Months
GlobeNewswire - Wed Jun 11, 7:00AM CDT
SmallCapVoice.com, Inc. announced today that a new audio interview with PositiveID Corporation ("PositiveID" or the "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, is now available. The interview can be heard at http://smallcapvoice.com/blog/6-9-14-smallcap...-corp-psid. PositiveID announces first-ever revenue guidance of USD4m-10m over next 18 months to increase its bio-threat detection technologies and programmes
M2 - Mon Jun 09, 7:35AM CDT
Biological detection company PositiveID (Other OTC
SID) disclosed on Friday the submission of bids and proposals in conjunction with several large commercial partners under the new US government procurements for bio-threat detection rise. PositiveID Issues First-Ever Revenue Guidance of $4-10 Million Over Next 18 Months as Government Procurements for Bio-Threat Detection Increase
GlobeNewswire - Fri Jun 06, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, announced today that it has submitted bids and proposals in conjunction with several large commercial partners in response to a pick-up in new U.S. government procurements for bio-threat detection. As a result, PositiveID is issuing its first-ever revenue guidance of $4-10 million over the next 18 months, $3.3 million of which is already in backlog. PositiveID Corporation Updates Stockholders on 2014 Progress
GlobeNewswire - Tue May 27, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today provided an update to stockholders on its 2014 progress. Year to date, the Company has achieved several key goals through the signing of agreements with large commercial and federal government organizations, including revenue generation. Limitless Venture Group's Stock Volume Soars On News of Hemp-Based Products
ACCESSWIRE - Wed Apr 02, 8:41AM CDT
Limitless Venture Group Inc.'s (OTCPINK: LVGI) stock volume skyrocketed Apr. 1, with 292,012,825 shares changing hands, nearly three times more than its three-month average volume of 107,767,353 shares.
The Market and Potential for Molecular Point of Care Diagnostics Report Provides Market Estimates up to 2018
M2 - Mon Mar 31, 11:27AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gb6tbz/the_market_and) has announced the addition of the "The Market and Potential for Molecular Point of Care Diagnostics" report to their offering. The molecular diagnostic market and the point-of-care (POC) testing markets are two of the fastest growing segments of the overall IVD market. Historically, these have been completely different market segments. Not anymore. There has been a growing interest in developing molecular diagnostic platforms that can be used in POC settings. Indeed, as this new market research report details, the emerging area of rapid molecular POC testing has attracted over $650 million in investments and financings over the past five years (2009 to 2013). The Market and Potential for Molecular Point of Care Diagnostics, offers a quantitative assessment of the molecular diagnostic market, and of the point-of-care (POC) testing market, and then looks at the emerging field of molecular diagnostic POC testing. Many companies are developing molecular diagnostic platforms and assays that are designed to for near-patient or POC testing, and the earliest of these systems are starting to reach the market. The initial market focus for most of these companies is on infectious disease testing, where rapid test results generate important actionable information that physicians can use to make treatment decisions. Over 75 companies involved in this market are profiled in this report. As expected with any group of start-up companies, many are struggling or are surviving on limited financial resources. However, some new companies that are focusing on molecular diagnostic POC testing have received significant investments. Some of the Companies Mentioned: - Abacus Diagnostica Oy - bioMerieux sa - Canon U.S. Life Sciences - DiaSorin S.p.A. - Espira, Inc. - Focus Diagnostics, Inc. - GenePOC Inc. - Instrumentation Laboratory - Lumora Ltd - Meridian Bioscience, Inc. - NetBio, Inc. - OptiGene Ltd. - PositiveID Corporation - QIAGEN N.V - Spartan Bioscience Inc. - Veredus Laboratories - Wave 80 Biosciences - Xagenic Inc. For more information visit http://www.researchandmarkets.com/research/gb...market_and About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
PositiveID Signs Agreement With Unit of UTC Aerospace Systems for U.S. Government Contract
GlobeNewswire - Mon Mar 31, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, is proud to announce that it has signed a contract with UTC Aerospace Systems' ISR & Space Systems unit to support a contract for the U.S. Department of Defense ("DoD" . This contract is expected to be performed over the next seven months, between March and September, 2014. PositiveID Corporation's CEO to Present at InvestorIdeas.com Security and Defense Conference on March 11, 2014 in New York City
GlobeNewswire - Wed Mar 05, 7:42AM CST
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that its Chairman and CEO, William J. Caragol, will present at the InvestorIdeas.com Security and Defense Conference at 3:30 pm on March 11, 2014, at the New York Hilton Midtown in New York City. The Company's presentation will be posted in the Investors & Media section of its website under Events & Presentations. 
